News & Events category:
Manchester Royal Infirmary

The first results of an early trial of a multivariant COVID-19 vaccine booster, launched in Manchester in September 2021, has shown it is driving a comprehensive immune response.

A trainee surgeon at Manchester Royal Infirmary (MRI) was recently awarded a prestigious national honour for his contributions to transplant research.

Children with adrenal insufficiency have a higher risk of dying than those with other lifelong conditions, according to research by The University of Manchester and MFT scientists.

Implantable heart technology is being used in Manchester to assess when a patient is at high risk of dying, thanks to Manchester University NHS Foundation Trust-led research.

Dr Stephanie Ling, Clinical Research Fellow at Manchester Royal Infirmary, discusses working with rheumatoid arthritis patients through research to improve biologic treatments.

A phase one trial of one of the world’s first multivariant COVID-19 Vaccine has been launched by US pharmaceutical company Gritstone, in collaboration with MFT.

The Chief Operating Officer of the NIHR  Clinical Research Network (CRN) Greater Manchester has volunteered to take part in a COVID-19 booster vaccine study.

A young lupus patient is encouraging others to take part in research, after she volunteered for the NIHR Immune-Mediated Inflammatory Diseases (IMID) BioResource.